Baird Upgrades Envista Holdings (NVST) Stock to Outperform, Raises PT

On May 27, Baird analyst Jeff Johnson upgraded the stance on Envista Holdings Corporation (NYSE:NVST)’s stock from “Neutral” to “Outperform,” and raised its price objective to $23.00 from the prior target of $21.00, as reported by The Fly.

A close-up of a dental bracket and wires being fitted into a patient’s mouth.

The firm’s May domestic dental survey showed an improvement following the disappointing April findings. The firm added that its feedback continues to hint at stable-to-slightly improved dental demand over the last couple of months, including in the US.

The firm expects revenue and earnings upside for Envista Holdings Corporation (NYSE:NVST) in 2025 and 2026. Baird also added that stable end markets and the recent relief to China on tariffs are some of the factors likely to support the upside over the next couple of quarters.

Envista Holdings Corporation (NYSE:NVST) highlighted that the global dental market remained stable in Q1 2025 as the underlying demand remained similar to what the company saw in H2 2024. Amidst geopolitical uncertainty, the company continues to ramp up its mitigating actions to further increase its resiliency. Notably, the restructuring and additional cost controls continue to result in G&A productivity across the company.

Envista Holdings Corporation (NYSE:NVST) is engaged in developing, manufacturing, marketing, and selling dental products.

While we acknowledge the potential of NVST to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk.  If you are looking for an AI stock that is more promising than NVST and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now

Disclosure: None.